Research reveals new IgM antibodies to fight COVID-19 more potent than commonly used ones
New tech predicts chemotherapy effectiveness after one treatment
3 June 2021Modeling COVID’s impact on pregnancy and birth trends
3 June 2021Research reveals new IgM antibodies to fight COVID-19 more potent than commonly used ones
A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal models, according to research recently published by The University of Texas Health Science Center at Houston (UTHealth), The University of Texas Medical Branch at Galveston (UTMB Health), the University of Houston, and IGM Biosciences, Inc. The study was published today in Nature.
